Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The medication completed phase 2 trials in 2023
These researchers usually purchase in the small bulk range, motivated primarily by cost savings and supply security
Your doctor can help you build a plan that works with the options you actually have.
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes
This was evidenced by increased alkaline phosphatase (ALP) activity, enhanced mineralization, and upregulation of osteogenic markers such as osteocalcin (OCN) and Runt-related transcription factor 2 (RUNX2)
US$ 22.43
US$ 20.34
US$ 23.05
US$ 22.72
US$ 26.72
